TB-500 on its own record
TB-500 is the research-supply name for a synthetic peptide corresponding to the actin-binding region of thymosin beta-4, a naturally occurring 43-residue protein. It is studied in cell-migration, actin-polymerisation and tissue-repair model systems. TB-500 is not an approved medicine, is prohibited in sport, and is supplied for in vitro laboratory research only.
Chemical name: Synthetic thymosin beta-4 fragment (research supply designation TB-500).
Common synonyms: Thymosin beta-4 fragment, TB4 fragment, LKKTETQ peptide.
Parent protein: Thymosin beta-4 (43 residues).
Appearance: White lyophilised powder.
TB-500 5mg is the 5 mg lyophilized unit, listed at AED 349 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.
How TB-500 differs from the linked records
TB-500 versus BPC-157. BPC-157 literature emphasizes gastric-derived pentadecapeptide sequences; TB-500 references Thymosin Beta-4 fragment research. BPC-157 is listed with CAS 137525-51-0. A certificate for BPC-157 does not qualify a TB-500 vial, and the reverse is also true. Read BPC-157 on its own monograph rather than inferring it from this page.
TB-500 versus GHK-Cu. TB-500 is catalogued as a Actin-binding peptide fragment. GHK-Cu is catalogued as a Copper-binding tripeptide (Cosmetic & cellular research). They are separate records. GHK-Cu is listed with CAS 89030-95-5. A certificate for GHK-Cu does not qualify a TB-500 vial, and the reverse is also true. Read GHK-Cu on its own monograph rather than inferring it from this page.
TB-500 versus Wolverine. TB-500 is catalogued as a Actin-binding peptide fragment. Wolverine is catalogued as a Dual-peptide research blend (Research blends). They are separate records. Wolverine is listed with CAS Not applicable — composite material. A certificate for Wolverine does not qualify a TB-500 vial, and the reverse is also true. Read Wolverine on its own monograph rather than inferring it from this page.
TB-500 versus KLOW. TB-500 is catalogued as a Actin-binding peptide fragment. KLOW is catalogued as a Multi-peptide research blend (Research blends). They are separate records. KLOW is listed with CAS Not applicable — composite material. A certificate for KLOW does not qualify a TB-500 vial, and the reverse is also true. Read KLOW on its own monograph rather than inferring it from this page.
Certificates do not cross over
Lot VL-TB500-20260917 is the catalogue certificate for TB-500 5mg. Read it on TB-500 5mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
If a purchase order says TB-500, a vial of a related compound does not satisfy it. If the order names a strength, a different strength of TB-500 does not satisfy it either.
What this comparison refuses to do
It does not rank TB-500 against another material, recommend a combination, or translate a paper into a dose. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Prices and the literature notes are on the TB-500 research summary. Sealed-unit handling is the TB-500 storage guide. The TB-500 compound monograph remains the long record.
VaultLabs dispatches TB-500 from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.